Altogether, these findings suggested that HAT1 transcriptionally regulate PD-L1 expression in cancer settings, and implicated that targeting HAT1 activity could be used as a therapeutic approach for cancer treatment (99) (Figure 3B, i). This evidence concerns the gene HAT1 and cancer.